O.K. PROBIO5 is the currently debated topic along with threelac.
I just have one question: How can something that sounds so gross (Enterococcus Faecalis) actually be good for you? If it is I stand corrected (and please correct me), but this is the main reason that I bought PROBIO5 a while ago.
This information was sent to me today direct from GHT. This should help in clearing up the misunderstood ingredient in the product.
The three probiotic organisms in ThreeLac are known to be assertive toward some of the more common strains of yeast and fungi. Similar to, but not identical to acidophilus, bifidus and other friendly flora, ThreeLac organisms works well along with those, but do not replace the other friendly flora in their specific functions. These organisms are:
Bacillus Subtilis – A gram-positive, rod-shaped, endospore-forming, aerobic bacterium. It is found in soil and is non-pathogenic The value of externally-supplied live bacteria for the maintenance of health in humans has been recognized both scientifically in the published literature and commercially in the availability of probiotic products. It has been found to be harmless to humans or the environment.
Bacilus Coagulans – A gram-positive, endospore-forming, lactic-acid producing bacterium used in Japan for over twenty years. It represents a significant breakthrough in Lactobacillus supplementation as a safe, effective probiotic which needs no special handling, survives in stomach acid. Bacillus Coagulans is considered semi-resident, meaning that it takes up only temporary residence in the human intestines.
Enterococcus Faecalis - Enterococci are gram-positive, spherical bacterium that colonize in groups or chains. This organism is naturally found (resident) as part of the digestive tract flora in intestines of mammals, including humans. 3 In the healthy intestinal tract they take their place among hundreds of other friendly flora and function as part of the normal eco-system.4 Clinical studies have been performed on certain strains of Enterococcus Faecalis, showing them to be non-pathogenic.5 The ThreeLac manufacturer has given assurance that the Enterococcus Faecalis strain used in ThreeLac does not have the virulent properties of some other strains. These three strains do not come from animals; they are isolated, purified and cultured by growing them on nutrient media, according to the manufacturer.
We are sometimes asked if taking too much ThreeLac could produce an overgrowth of these organisms,
and the answer is that it could not. ThreeLac has been a top in-demand GHT product and has been used successfully by tens of thousands internationally. Those, however, who have compromised immune function or who are under the care of a physician should consult with their healthcare practitioner before taking ThreeLac, as with any product new to them.
Enterococcus faecalis is an opportunistic bacterium that has become one of the most troublesome hospital pathogens. It has intrinsic resistance to many antibiotics and a remarkable capacity for developing resistance to others
Enterococcus faecalis is a Gram-positive, facultatively anaerobic, cocci which occurs singly, in pairs or short chains. It is a normal inhabitant of the intestinal tract and female genital tract.
Scientists have identified a virulence region never seen before in the genome of Enterococcus faecalis - a leading cause of bacterial infection among hospital patients. This bacterium lives peacefully in the human gut, but it also thrives on wounds and burns. Researchers have identified a group of genes that may contribute to the bacterium's transformation from being harmless in the gut to a menacing invader. There has long been concern about the dangers of antibiotic resistance and its implications for the return of infectious diseases that cannot be effectively treated. It is argued that hospitals are not only spreading bacteria from patient to patient, but are also harbouring a tougher breed of bug-one that is resistant to antibiotics.
The sequencing of the genome reinforces knowledge of the remarkable fluidity of the bacterial gene pool. This fluidity allows bacteria to exchange DNA to enhance their ability to cause disease or their resistance to antibiotics.
Generally these microbes live harmlessly in the intestine however until the entire genome was sequenced, scientists did not realise that a quarter of enterococcus' genome is made-up of mobile DNA and within these regions are genes for vancomycin resistance and for virulence. Vancomycin is the last-resort antibiotic in fighting infection.
Enterococcus faecalis is extremely hardy and can survive for weeks on environmental surfaces; cheese - 180 days; soil up to 77 days; soiled linen up to 90 days, cultures at -70� C for several years.